LifeSci Advisors' Board Placement Initiative Announces Ninth Board Placement
(Thomson Reuters ONE) -
NEW YORK, June 23, 2017 (GLOBE NEWSWIRE) -- LifeSci Advisors, a leading life
sciences-focused investor relations consultancy, announced today the ninth
placement of a female executive to a life sciences company board as part of
their Board Placement Initiative (BPI), a program launched a year ago with the
goal to connect female executives in the life sciences industry with companies
looking for board candidates. LifeSci is pleased to share news of
the appointment of Jean M. Franchi to the Board of Directors of Biophytis, a
biotech company listed on Euronext Paris (ALBPS) focused on drugs that target
diseases of aging, with drug candidates in clinical development for dry AMD and
Sarcopenia.
"I'm honored to join the Biophytis board, and look forward to helping the
company achieve a more global presence as it advances its portfolio of
innovative therapies addressing unmet needs associated with aging," said Ms.
Franchi. "I want to extend my kind thanks to LifeSci for the introduction
through its important initiative, BPI."
Ms. Franchi brings more than 30 years of financial experience in biotechnology,
including her role as Chief Financial Officer of Dimension Therapeutics and,
previously, Good Start Genetics. At Dimension, she played a significant role in
successfully introducing the company onto the NASDAQ stock exchange in 2015.
Previously, Ms. Franchi spent 16 years at Genzyme Corporation, where she held
roles of increasing responsibility and was instrumental in preparing the company
for its transition from early market introductions to becoming the industry
leader in rare disease drug development and commercialization. Earlier in her
career, Ms. Franchi worked in accounting, finance, and sales operations for two
diagnostic companies: bioMérieux, Inc., and API, a former division of American
Home Products (now Pfizer).
"Jean's decades of experience in finance and success with the biotech IPO
process will make her an asset to the Biophytis board," said Michael Rice,
Founding Partner, LifeSci Advisors. "We are thrilled that LifeSci Advisors'
Board Placement Initiative has been able to play a role in facilitating this
appointment."
LifeSci Advisors' Board Placement Initiative is accepting resumes from
interested candidates and referrals on an ongoing basis. Resumes or open board
seat positions can be sent to boarddiversity(at)lifesciadvisors.com. You can find
out more information about BPI and LifeSci Advisors' commitment to board
diversity by visiting www.lifesciadvisors.com/board-diversity-initiatives.
About LifeSci Advisors, LLC:
LifeSci Advisors, LLC (www.lifesciadvisors.com) is a unique investor relations
consultancy founded to provide companies in the life sciences a comprehensive
solution to investor communications and outreach. With a local presence in New
York, Boston, Chicago, Philadelphia, London, Geneva and Tel Aviv, the firm
provides the highest quality service for its clients through its deep sector
specialization. Our roster of PhDs enables us to better understand our clients'
R&D, regulatory, and commercial strategy, and our team of capital markets,
investor relations, and public relations specialists help our clients
effectively communicate to the marketplace. This combination of life sciences,
capital markets, and investor relations competencies allows us to provide a
valuable and highly differentiated service offering to our clients.
About LifeSci Partners:
LifeSci Partners (www.lifescipartners.com) is the leading provider of
comprehensive consulting services in the areas of investor relations, corporate
communications, public relations and capital markets advisory. Combining deep
domain expertise in the life sciences and decades of experience in capital
markets and public relations, we deliver unparalleled services to life sciences
companies globally. LifeSci Partners has a physical presence in New York,
Boston, Chicago, Philadelphia, London, Geneva and Tel Aviv.
For further information, please contact:
Michael Rice
Founding Partner
LifeSci Advisors, LLC
(646) 597-6979
mrice(at)lifesciadvisors.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: LifeSci Advisors, LLC via GlobeNewswire
Datum: 23.06.2017 - 17:52 Uhr
Sprache: Deutsch
News-ID 549581
Anzahl Zeichen: 4947
contact information:
Town:
New York
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 243 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"LifeSci Advisors' Board Placement Initiative Announces Ninth Board Placement"
steht unter der journalistisch-redaktionellen Verantwortung von
LifeSci Advisors, LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
